Sign up to save your podcasts
Or
Share E16: Tocilizumab in Giant-Cell Arteritis - GIACTA
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
E16: Tocilizumab in Giant-Cell Arteritis - GIACTA
Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone. It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.
View all episodes
By Michael Putman
4.9
113113 ratings
Getting back to our usual format, this week we'll discuss the GIACTA trial, which compared various schedules of tocilizumab to various schedules of placebo and prednisone. It's an important trial that has changed the face of GCA and will be a refreshing RCT to discuss before we dive back into garbagey data next week.
More shows like The Evidence Based Rheumatology Podcast
View all
NEJM This Week
323 Listeners
JAMA Clinical Reviews
499 Listeners
This Week in Cardiology
876 Listeners
Rheumnow Podcast
131 Listeners
Core IM | Internal Medicine Podcast
1,146 Listeners
Healio Rheuminations
121 Listeners
Annals On Call Podcast
192 Listeners
Freely Filtered, a NephJC Podcast
172 Listeners
ACR on Air
67 Listeners
Run the List
247 Listeners
Around the Rheum with Drs. Daniel Ennis & Janet Pope
4 Listeners
Rheumatology For The Royal College
183 Listeners
RheumMadness Rheumatology Podcast
11 Listeners
ACR Journals On Air
18 Listeners
Talking Rheumatology Spotlight
6 Listeners